R&D A greener catalysis: Talking sustainable, scalable chemistry... As King’s College London (KCL) scientists are once more in the headlines – this time with new ‘plug and play’ drug delivery technology that could offer a
Partner Content Partner Content SMi’s 3D Cell Culture conference 2020 – Speakers announced SMi’s 3D Cell Culture conference 2020 – Speakers
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face